Avenir Wellness Solutions, Inc. (OTCPK:CURR) released results for the quarter ended March 31, 2023, revealing net revenue of $1.2 million, an increase of 15.1% year-over-year and 35.6% sequentially from Q4 2022.
Q1 2023 Financial Highlights
CURE Pharmaceutical Holding Corp. (OTCQB: CURR) revenue in the third quarter increased 32.1% year-over-year and 58.9% sequentially from Q2 2022 to $1.8 million.